FDA Drug Recalls

Recalls / Class III

Class IIID-0024-2026

Product

Ketamine Hydrochloride, 50mg/5 mL (10mg/mL), Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0156-02.

Affected lot / code info
Lot #: 25156673A, Expiry: 02FEB2026.

Why it was recalled

Labeling: Incorrect or Missing Lot and/or Exp Date

Recalling firm

Firm
STAQ Pharma, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
14135 E 42nd Ave Ste 50, Denver, Colorado 80239-5214

Distribution

Distribution pattern
Nationwide in the U.S.

Timeline

Recall initiated
2025-10-09
FDA classified
2025-10-15
Posted by FDA
2025-10-22
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0024-2026. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: drug · FDA Drug Recalls